Original language | English (US) |
---|---|
Pages (from-to) | S2-S8 |
Journal | Neurology |
Volume | 75 |
Issue number | 18 SUPPL.1 |
DOIs | |
State | Published - Nov 2 2010 |
Externally published | Yes |
Bibliographical note
Funding Information:Dr. Schmalstieg reports no disclosures. Dr. Weinshenker has served on data safety monitoring boards for Novartis and Biogen Idec; serves on the editorial boards of Multiple Sclerosis , the Canadian Journal of Neurological Sciences , and the Turkish Journal of Neurology ; receives research support from the Guthy-Jackson Charitable Foundation; and receives license royalties from RSR Ltd. and may receive royalties from Mayo Medical Ventures for a patent/intellectual property re: Aquaporin-4 associated antibodies for diagnosis of neuromyelitis optica.